冠心病高血压合并高血糖患者出现氯吡格雷抵抗:涉及血小板ATP含量增高及线粒体膜电位降低
DOI:
作者:
作者单位:

(1.清华大学第一附属医院 北京华信医院心内科,北京市 100016;2.解放军总医院心内科,北京 100853)

作者简介:

黄婷婷,硕士研究生,研究方向为冠心病抗血小板治疗,E-mail为christinehuang@126.com。

通讯作者:

基金项目:


Clopidogrel resistance in coronary artery disease and hypertension patients with high blood sugar:involving increased platelet ATP content and mitochondrial membrane potential decreased
Author:
Affiliation:

1.Department of Cardiology, the First Hospital of Tsinghua University, Beijing Huaxin Hospital,Beijing 100016, China;2. Department of Cardiology, General Hospital of Chinese People's Liberation Army, Beijing 100853, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 从血小板能量代谢角度分析,以分子生物学指标检测为手段,分析高血糖诱发氯吡格雷抵抗(CR)的原因。 方法 随机纳入确诊为冠心病(CAD)且伴有高血压(HPT)的患者122例,根据血栓弹力图(TEG)中ADP途径抑制率的50%为界限,将患者分为氯吡格雷低反应组(LRG)和氯吡格雷反应组(RG)。成功取样进入实验的LRG中合并高血糖患者19例(合并高血糖组);RG中无糖尿病并此次入院糖耐量试验正常者20例(无高血糖组)。采取荧光素/荧光素酶法检测新鲜血液血小板ATP含量及流式细胞仪技术测血小板线粒体膜电位(Δψm)。比较合并高血糖组与无高血糖组血小板ATP含量及Δψm差异,多元逐步回归分析其与各基线参数的相关性。 结果 合并高血糖组患者血小板ATP含量明显高于无高血糖组(4.369±2.174比1.628±0.452 mmol/g, P<0.001),而血小板线粒体膜电位(Δψm)前者则显著低于后者(0.484±0.118比2.381±0.194,P<0.001)。逐步回归分析显示,糖化血红蛋白(HbAlc)与血小板ATP含量呈正相关(β=1.235; P=0.000),与Δψm呈负相关(β=-0.54; P=0.000)。患者年龄也列入回归方程(β=0.03; P=0.006),但不如HbAlc与Δψm的相关性显著。 结论 高血糖促使血小板产生更多的ATP,导致血小板活性增高,使合并高血糖的冠心病高血压患者更易发生氯吡格雷抵抗。同时,高血糖使血小板Δψm降低,促进血小板提早凋亡,间接诱发CR可能。

    Abstract:

    Aim To find the causes of clopidogrel resistance caused by high blood glucose from the view of platelet energy metabolism by detection of molecular markers. Methods About 122 patients with coronary artery disease (CAD) accompanying hypertension (HPT) were randomly analyzed. The patients were divided into low response group (LRG) and response group (RG) according to the inhibition of their platelet through the way of ADP inhibition rate in thrombelastogram (TEG). 19 cases (hyperglycemia group)were randomly selected from the group of LRG with hyperglycemia, and 20 cases (no hyperglycemia group) were randomly selected from the group of RG without diabetes or with normal glucose tolerance test. Fresh platelets were isolated for ATP and mitochondrial membrane potential (Δψm) analysis. ATP contents were determinated by luciferin/luciferase luminometric method, and the flow cytometry technique was adopted to evaluate Δψm. In all participants correlation between platelet ATP content, Δψm and other variables was analyzed by a multivariable stepwise regression. Results Platelet ATP contents were significantly higher in hyperglycemia group (4.369±2.174 mmol/g) than in no hyperglycemia group (1.628±0.452 mmol/g; P<0.001). Interestingly, Δψm was markedly decreased in patients of hyperglycemia group (0.484±0.118) compared with no hyperglycemia group (2.381±0.194; P<0.001). For whole subjects, a liner stepwise regression showed that plasma glycated hemoglobin A1c (HbA1c) level was positively correlated to platelet ATP content (β=1.235; P=0.000), and negatively correlated to Δψm (β=-0.54; P=0.000). Although, the age of the patients was involved in the regression equation, but significant correlation (β=0.03; P=0.006) was found between Δψm and HbAlc instead of age. Conclusion High blood glucose leads platelet to produce more ATP, resulting in increased platelet activity, making it easier for patients with high blood glucose to develop Clopidogrel resistance (CR). At the same time, high blood glucose reduces the Δψm of platelets, promoted early apoptosis, indirect CR may be induced.

    参考文献
    相似文献
    引证文献
引用本文

黄婷婷,苗立夫,易军,任艺虹.冠心病高血压合并高血糖患者出现氯吡格雷抵抗:涉及血小板ATP含量增高及线粒体膜电位降低[J].中国动脉硬化杂志,2017,25(10):1025~1030.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2017-06-08
  • 最后修改日期:2017-07-05
  • 录用日期:
  • 在线发布日期: 2017-11-28